ARTICLE | Distillery Therapeutics
miR-17-92 gene therapy for ALS associated with SOD1 mutations
June 26, 2019 11:34 PM UTC
INDICATION: Amyotrophic lateral sclerosis (ALS)...
BCIQ Company Profiles
BCIQ Target Profiles
Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
INDICATION: Amyotrophic lateral sclerosis (ALS)...
BCIQ Company Profiles
BCIQ Target Profiles